PRESS RELEASE published on 01/24/2024 at 14:00, 2 years 7 months ago AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
PRESS RELEASE published on 09/28/2023 at 14:00, 2 years 11 months ago AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
PRESS RELEASE published on 08/23/2023 at 14:00, 3 years ago AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
PRESS RELEASE published on 07/06/2023 at 14:00, 3 years 2 months ago AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
PRESS RELEASE published on 04/04/2023 at 14:00, 3 years 5 months ago AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Published on 09/05/2026 at 04:05, 1 day 10 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 1 day 15 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 1 day 16 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 1 day 16 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/06/2026 at 12:30, 2 hours 34 minutes ago MERACH Introduces the UltraWalk W60 Plus - A Walking Pad Designed for the Modern Home and Home Office
Published on 09/06/2026 at 10:25, 4 hours 39 minutes ago Over 400 media professionals seek new drivers for Asia-Pacific growth
Published on 09/06/2026 at 10:00, 5 hours 4 minutes ago Haier Showcases AI-Powered Smart Home Ecosystem at IFA 2026
Published on 09/06/2026 at 06:00, 9 hours 4 minutes ago CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026
Published on 09/06/2026 at 05:15, 9 hours 49 minutes ago Experience AI Companion in Everyday Life at Hisense IFA 2026
Published on 09/04/2026 at 18:57, 1 day 20 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 1 day 20 hours ago Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 1 day 20 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 1 day 20 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 1 day 20 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026
